-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hemophagocytic lymphohistiocytosis is a rare and highly inflammatory disease with a poor prognosis
Recently, a research article was published in the Journal of Internal Medicine, an authoritative journal in the field of internal medicine.
Researchers used population-based linked data from England's primary care, secondary care, cancer registry, and mortality database to determine the diagnosis of hemophagocytic lymphohistiocytosis between January 1, 2000 and December 31, 2016 Individual
diagnosis
Researchers identified 214 patients with hemophagocytic lymphohistiocytosis
It can be seen that the diagnosis of hemophagocytic lymphohistiocytosis in England increased between 2000 and 2016
Diagnosis of hemophagocytic lymphohistiocytosis in England increased between 2000 and 2016
Original source:
Joe West,et al.
Incidence and survival of haemophagocytic lymphohistiocytosis: A population-based cohort study from England
in this message